Current Assets
Restricted Cash
Neurocrine Biosciences Restricted Cash remained flat by 0.0% to $8M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $8M to $8M.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2014
Last reportedQ1 2026May 5, 2026
Metric ID:
restricted_cashHistorical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $371.2M | $314.3M | $278M | $171.1M | $7.8M | $111.6M | $168.2M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M |
| QoQ Change | — | -15.3% | -11.5% | -38.5% | -95.4% | >999% | +50.7% | -95.2% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | -53.9% | -97.5% | -59.9% | -1.7% | +2.6% | -92.8% | -95.2% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
Range$7.8M – $371.2M
CAGR-66.6%
Avg YoY Growth-33.2%
Median YoY Growth-0.8%
Current Streak7 quarters growth
Restricted Cash at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's restricted cash?
- Neurocrine Biosciences (NBIX) reported restricted cash of $8M in Q1 2026.
- How has Neurocrine Biosciences's restricted cash changed year-over-year?
- Neurocrine Biosciences's restricted cash decreased by 0.0% year-over-year, from $8M to $8M.